FDA Delays Enforcement of Certain DSCSA Requirements Until November 2024 

Posted by

Illustration of gavel and paper.

Food and Drug Administration (FDA) has published final guidance delaying enforcement of certain Drug Supply Chain Security Act (DSCSA) requirements until November 27, 2024. The extension will give trading partners (drug and device manufacturers, wholesale distributors, dispensers, and repackagers) additional time to further “develop and refine appropriate systems and processes to conduct interoperable, electronic tracing […]

Read More ›

DEA Amends Regulations for Reporting Theft or Significant Loss of CS

Posted by

Illustration of gavel and paper.

Drug Enforcement Administration (DEA) published a final rule amending the regulations regarding DEA Form 106, which is used by DEA registrants to formally report thefts or significant losses of controlled substances (CS). DEA registrants are now required to submit all forms reporting thefts or losses electronically through DEA’s secure online database. The final rule went […]

Read More ›

PTCB Launches New Regulatory Certificate

Posted by

Illustration of pill bottle.

The Pharmacy Technician Certification Board (PTCB) has created a new Regulatory Compliance Certificate to provide technicians with the opportunity to demonstrate their knowledge and proficiency regarding pharmacy laws, regulations, legal requirements, and practice standards to maintain compliance and quality assurance in various practice settings. Eligible candidates must hold an active PTCB Certified Pharmacy Technician certification […]

Read More ›

HHS Expands Access Toward Lifesaving Addiction Treatment

Posted by

Illustration of gavel and paper.

The United States Department of Health and Human Services (HHS) has expanded practice guidelines allowing certain practitioners who are state licensed and registered by Drug Enforcement Administration (DEA) to have the ability to more easily prescribe buprenorphine to patients with opioid use disorder (OUD). The expansion scales back the DEA “X-waiver” to further expand patient […]

Read More ›
Page 1 of 1